1. Home
  2. ENS vs SYRE Comparison

ENS vs SYRE Comparison

Compare ENS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EnerSys

ENS

EnerSys

HOLD

Current Price

$190.24

Market Cap

7.5B

Sector

Technology

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$100.04

Market Cap

6.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENS
SYRE
Founded
1991
2013
Country
United States
United States
Employees
9200
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
6.5B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
ENS
SYRE
Price
$190.24
$100.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$193.00
$85.08
AVG Volume (30 Days)
420.5K
1.2M
Earning Date
05-20-2026
05-08-2026
Dividend Yield
0.51%
N/A
EPS Growth
N/A
N/A
EPS
7.70
N/A
Revenue
$216,125,000.00
N/A
Revenue This Year
$4.49
N/A
Revenue Next Year
$3.41
N/A
P/E Ratio
$24.77
N/A
Revenue Growth
15.85
N/A
52 Week Low
$89.49
$14.51
52 Week High
$244.30
$105.09

Technical Indicators

Market Signals
Indicator
ENS
SYRE
Relative Strength Index (RSI) 35.69 57.68
Support Level $152.19 $92.37
Resistance Level $194.77 $103.58
Average True Range (ATR) 6.95 5.84
MACD -0.75 -0.22
Stochastic Oscillator 11.66 67.19

Price Performance

Historical Comparison
ENS
SYRE

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, New Ventures, and Specialty.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: